The occurrence of neuropathic pain following surgery of brainstem cavernous malformations von Herten, Annika, Saban, Dino, Santos, Alejandro N., Chen, Bixia, Darkwah Oppong, Marvin, Rauschenbach, Laurèl, Jabbarli, Ramazan, Wrede, Karsten, Bingel, Ulrike, Müller, Daniel, Holle‐Lee, Dagny, Schmidt, Börge, Li, Yan, Sure, Ulrich, Dammann, Philipp

Volltext

Treatment of Persistent Postural-Perceptual Dizziness (PPPD) and Related Disorders von Popkirov, Stoyan, Stone, Jon, Holle-Lee, Dagny

Volltext

Hypnic Headache – What do we know in 2022? von Lindner, Diana, Scheffler, Armin, Nsaka, Michael, Holle-Lee, Dagny

Volltext

Impact of a 12-week open-label placebo treatment on headache days in episodic and chronic migraine: a study protocol for a parallel-group, multicentre, randomised controlled trial von Schmidt, Katharina, Kleine-Borgmann, Julian, Holle-Lee, Dagny, Gaul, Charly, Bingel, Ulrike

Volltext

Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-control... von Nahas, Stephanie J., Naegel, Steffen, Cohen, Joshua M., Ning, Xiaoping, Janka, Lindsay, Campos, Verena Ramirez, Krasenbaum, Lynda J., Holle-Lee, Dagny, Kudrow, David, Lampl, Christian

Volltext

Prevention of medication overuse and medication overuse headache in patients with migraine: a randomized, controlled, parallel, allocation-blinded, multicenter, prospective trial u... von Diener, Hans-Christoph, Donoghue, Stephen, Gaul, Charly, Holle-Lee, Dagny, Jöckel, Karl-Heinz, Mian, Alec, Schröder, Bernadette, Kühl, Tobias

Volltext

Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline von Diener, Hans-Christoph, Kropp, Peter, Dresler, Thomas, Evers, Stefan, Förderreuther, Stefanie, Gaul, Charly, Holle-Lee, Dagny, May, Arne, Niederberger, Uwe, Moll, Sabrina, Schankin, Christoph, Lampl, Christian

Volltext

Noninvasive vagus nerve stimulation in the management of cluster headache: clinical evidence and practical experience von Holle-Lee, Dagny, Gaul, Charly

Volltext

Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, pla... von Nahas, Stephanie J., Naegel, Steffen, Cohen, Joshua M., Ning, Xiaoping, Janka, Lindsay, Campos, Verena Ramirez, Krasenbaum, Lynda J., Holle-Lee, Dagny, Kudrow, David, Lampl, Christian

Volltext

Prevention of migraine with monoclonal antibodies against CGRP or the CGRP receptor von Diener Hans-Christoph, derreuther Stefanie, Gaul Charly, Giese Florian, Hamann Till, Holle-Lee, Dagny, Jürgens, Tim P, Kamm Katharina, Kraya Torsten, Lampl, Christian, May, Arne, Reuter, Uwe, Scheffler Armin, Tfelt-Hansen Peer

Volltext

Corneal Confocal Microscopy Demonstrates Corneal Nerve Loss in Patients With Trigeminal Neuralgia von Lee, John-Ih, Böcking, Theresa, Holle-Lee, Dagny, Malik, Rayaz A., Kieseier, Bernd C., Hartung, Hans-Peter, Guthoff, Rainer, Kleinschnitz, Christoph, Stettner, Mark

Volltext

The beneficial effect of positive treatment expectations on pharmacological migraine prophylaxis von Schmidt, Katharina, Berding, Tobias, Kleine-Borgmann, Julian, Engler, Harald, Holle-Lee, Dagny, Gaul, Charly, Bingel, Ulrike

Volltext

Digitalisierung in der Diagnostik und Therapie von Kopfschmerzen von Holle-Lee, Dagny

Volltext

Visual snow syndrome is probably not mediated by CGRP: A case series von Evers, Stefan, Holle-Lee, Dagny, Schankin, Christoph J, Kull, Pia, Raffaelli, Bianca

Volltext

Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial

Volltext

The beneficial effect of positive treatment expectations on pharmacological migraine prophylaxis von Schmidt, Katharina, Berding, Tobias, Kleine-Borgmann, Julian, Engler, Harald, Holle-Lee, Dagny, Gaul, Charly, Bingel, Ulrike

Volltext

Timing and Location of Injection-site Adverse Events With Fremanezumab in Patients With Migraine: A Pooled Analysis of Phase 3 Studies (P16-2.003) von Dagny, Holle Lee, Kessler, Yoel, Campos, Verena Ramirez, Ning, Xiaoping, Cohen, Joshua M., Barash, Steve, Jürgens, Tim

Volltext

Benefit-risk assessment based on number needed to treat and number needed to harm: Atogepant vs. calcitonin gene–related peptide monoclonal antibodies von Ailani, Jessica, Lalla, Anjana, Halker Singh, Rashmi B, Holle-Lee, Dagny, Nagy, Krisztian, Kelton, Kari, Piron, Cristiano, Gandhi, Pranav, Pozo-Rosich, Patricia

Volltext

Prevalence and risk factors of migraine and non-migraine headache in older people – results of the Heinz Nixdorf Recall study von Schramm, Sara, Tenhagen, Isabell, Schmidt, Börge, Holle-Lee, Dagny, Naegel, Steffen, Katsarava, Zaza, Jöckel, Karl-Heinz, Moebus, Susanne

Volltext

Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial von Goadsby, Peter J, Friedman, Deborah I, Holle-Lee, Dagny, Demarquay, Genevieve, Ashina, Sait, Sakai, Fumihiko, Neel, Brian, Gandhi, Pranav, Dabruzzo, Brett, Smith, Jonathan H, Liu, Yingyi, Trugman, Joel M

Volltext